Congress trades
Intra-Cellular Therapies, Inc. (ITCI)
About Intra-Cellular Therapies, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Chief executive
- Sharon Mates
- Employees
- 860
- Listed since
- Jan 7, 2014
- Market value
- $14.0B
- Price to earnings
- -
- Earnings per share
- -$0.72
- Dividend yield
- -
www.intracellulartherapies.com
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q4 FY2024reported Feb 21, 2025 | -$0.16 | -$0.08 | $199.2M | $193.4M | EPS missRevenue beat |
| Q3 FY2024reported Oct 30, 2024 | -$0.25 | -$0.18 | $175.2M | $194.0M | EPS missRevenue miss |
| Q2 FY2024reported Aug 7, 2024 | -$0.16 | -$0.18 | $161.4M | $157.9M | EPS beatRevenue beat |
| Q1 FY2024reported May 7, 2024 | -$0.16 | -$0.31 | $144.9M | $141.4M | EPS beatRevenue beat |
| Q4 FY2023reported Feb 22, 2024 | -$0.30 | -$0.44 | $131.5M | $135.7M | EPS beatRevenue miss |
| Q3 FY2023reported Nov 2, 2023 | -$0.25 | -$0.59 | $125.8M | $136.9M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in ITCI
8 disclosures of 8 on record · median 24d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/a | Apr 3, 2025 | May 14, 2025 | 41d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | n/a | Apr 3, 2025 | May 6, 2025 | 33d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +0.3%S&P -1.1% · vs S&P 500 +1.4% | Mar 17, 2025 | Apr 10, 2025 | 24d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +0.1%S&P -2.6% · vs S&P 500 +2.7% | Mar 24, 2025 | Apr 7, 2025 | 14d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +3.6%S&P -7.7% · vs S&P 500 +11.3% | Jan 24, 2025 | Feb 10, 2025 | 17d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +72.2%S&P +2.8% · vs S&P 500 +69.4% | Jun 21, 2024 | Jul 9, 2024 | 18d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +173.6%S&P +21.2% · vs S&P 500 +152.4% | Dec 21, 2021 | Jan 10, 2022 | 20d |
| Roger MarshallDependent childFiled late | Stock | Purchase | $1,001 - $15,000 | +1157.1%S&P +135.4% · vs S&P 500 +1021.7% | May 1, 2017 | Aug 6, 2018 | 462d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded ITCI?
Josh Gottheimer, Gilbert Ray Cisneros, Jr., Roger Marshall disclosed ITCI transactions in the filings shown here.
How quickly are ITCI trades disclosed?
Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.